Altrinsic Global Advisors LLC Intra Cellular Therapies, Inc. Transaction History

Altrinsic Global Advisors LLC

  • $2.15 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$38.74 - $62.09 $3.1 Million - $4.97 Million
-80,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$28.72 - $42.49 $574,400 - $849,800
20,000 Added 33.33%
80,000 $2.98 Million
Q1 2021

May 14, 2021
BUY
$30.8 - $39.51 $1.85 Million - $2.37 Million
60,000 New
60,000 $2.04 Million

Others Institutions Holding ITCI

# of Institutions
379
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.87B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Altrinsic Global Advisors LLC Portfolio

Follow Altrinsic Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altrinsic Global Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email